Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 5Neoplasms 2Multiple Myeloma 2Cancer Pain 2Squamous Cell Carcinoma of Head and Neck 1Pain, Postoperative 1Paget Disease, Extramammary 1Ovarian Neoplasms 1Lymphoma 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Diseases 1Agnosia 1

Interventions

Morphine 6nabiximols 4Oxycodone 3Fentanyl 3Methadone 2Hydromorphone 2Acetaminophen 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1resiniferatoxin 1naloxegol 1Tapentadol 1Sugars 1Standard of Care 1Lidocaine 1Inosine Monophosphate 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Cancer Pain × Acetaminophen × Clear all
NCT05051735 2026-02-25

PARASTOP

Oslo University Hospital

Phase 3 Completed
204 enrolled

Cancer Pain, Neoplasms, Pain

NCT00152854 2016-03-08

Acetaminophen for Cancer Pain

University Health Network, Toronto

Phase 3 Completed
12 enrolled

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡